Stay updated on Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial page.

Latest updates to the Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated to version 2.16.5, indicating a new release. However, the previous information regarding the modernization of ClinicalTrials.gov data ingest has been removed.SummaryDifference4%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference4%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check42 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
- Check49 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
Stay in the know with updates to Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial page.